128 related articles for article (PubMed ID: 10228798)
21. Persistent E-cadherin expression in inflammatory breast cancer.
Kleer CG; van Golen KL; Braun T; Merajver SD
Mod Pathol; 2001 May; 14(5):458-64. PubMed ID: 11353057
[TBL] [Abstract][Full Text] [Related]
22. The E-cadherin adhesion molecule and colorectal cancer. A global literature approach.
Tsanou E; Peschos D; Batistatou A; Charalabopoulos A; Charalabopoulos K
Anticancer Res; 2008; 28(6A):3815-26. PubMed ID: 19189669
[TBL] [Abstract][Full Text] [Related]
23. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
24. Effects of changes at the site of E-cadherin expression as an indicator of colon cancer aggressiveness.
Guzińska-Ustymowicz K; Chetnik A; Kemona A
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():70-2. PubMed ID: 15638379
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
26. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
27. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas.
Wu H; Lotan R; Menter D; Lippman SM; Xu XC
Anticancer Res; 2000; 20(3A):1385-90. PubMed ID: 10928048
[TBL] [Abstract][Full Text] [Related]
28. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
29. Dedifferentiation and decreased expression of adhesion molecules, E-cadherin and ZO-1, in colorectal cancer are closely related to liver metastasis.
Kaihara T; Kusaka T; Nishi M; Kawamata H; Imura J; Kitajima K; Itoh-Minami R; Aoyama N; Kasuga M; Oda Y; Hattori M; Fujimori T
J Exp Clin Cancer Res; 2003 Mar; 22(1):117-23. PubMed ID: 12725331
[TBL] [Abstract][Full Text] [Related]
30. E-cadherin regulates the association between beta-catenin and actinin-4.
Hayashida Y; Honda K; Idogawa M; Ino Y; Ono M; Tsuchida A; Aoki T; Hirohashi S; Yamada T
Cancer Res; 2005 Oct; 65(19):8836-45. PubMed ID: 16204054
[TBL] [Abstract][Full Text] [Related]
31. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
[TBL] [Abstract][Full Text] [Related]
32. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
33. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
34. Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma.
Takamura M; Ichida T; Matsuda Y; Kobayashi M; Yamagiwa S; Genda T; Shioji K; Hashimoto S; Nomoto M; Hatakeyama K; Ajioka Y; Sakamoto M; Hirohashi S; Aoyagi Y
Cancer Lett; 2004 Aug; 212(2):253-9. PubMed ID: 15279905
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma].
Wang CX; Chen J; Yang Z; Song W; Du ZL; Li ZH
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188
[TBL] [Abstract][Full Text] [Related]
36. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
37. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR
J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065
[TBL] [Abstract][Full Text] [Related]
38. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.
Li YJ; Meng YX; Ji XR
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963
[TBL] [Abstract][Full Text] [Related]
39. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y
Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
